Google+ Badge

Monday, November 23, 2015

Cancer Research: Study,find ways to target rare tumor ♦ Intelligent gel attacks cancer ♦ Personalized drug screening on horizon for multiple myeloma patients

Researchers identify a new mode of drug resistance to emerging therapies in prostate cancer Advanced prostate cancer is a disease notoriously resistant to treatment. New research sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer. This discovery ultimately may help predict which patients may benefit most from treatment
New model to study, find ways to target rare tumor Angiosarcoma or lymphangiosarcoma, a rare malignant tumor of the blood or lymphatic vessels, has no cure, say cancer researchers. However, through recent study, a team has found a new target that could lead to therapies for this rare type of tumor.
Intelligent gel attacks cancer A new injectable “bio gel” is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer
Personalized drug screening on horizon for multiple myeloma patients A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process also may aid patients with leukemia or lymphoma

No comments:

Post a Comment